Service d'Anesthésie et de Réanimation, CHU de Poitiers, Poitiers, France; Université de Poitiers, UFR de Médecine Pharmacie, Poitiers, France; INSERM U1070, Pharmacologie des Agents antiInfectieux, Poitiers, France.
AP-HP, Bichat University Hospital, Infection Control Unit, Paris, France; INSERM, UMR 1137-IAME Team 5-DeSCID: Decision Sciences in Infectious Diseases, Control and Care, Paris, France; Univ Paris Diderot, Sorbonne Paris Cité, Paris, France.
Lancet. 2015 Nov 21;386(10008):2069-2077. doi: 10.1016/S0140-6736(15)00244-5. Epub 2015 Sep 18.
Intravascular-catheter-related infections are frequent life-threatening events in health care, but incidence can be decreased by improvements in the quality of care. Optimisation of skin antisepsis is essential to prevent short-term catheter-related infections. We hypothesised that chlorhexidine-alcohol would be more effective than povidone iodine-alcohol as a skin antiseptic to prevent intravascular-catheter-related infections.
In this open-label, randomised controlled trial with a two-by-two factorial design, we enrolled consecutive adults (age ≥18 years) admitted to one of 11 French intensive-care units and requiring at least one of central-venous, haemodialysis, or arterial catheters. Before catheter insertion, we randomly assigned (1:1:1:1) patients via a secure web-based random-number generator (permuted blocks of eight, stratified by centre) to have all intravascular catheters prepared with 2% chlorhexidine-70% isopropyl alcohol (chlorhexidine-alcohol) or 5% povidone iodine-69% ethanol (povidone iodine-alcohol), with or without scrubbing of the skin with detergent before antiseptic application. Physicians and nurses were not masked to group assignment but microbiologists and outcome assessors were. The primary outcome was the incidence of catheter-related infections with chlorhexidine-alcohol versus povidone iodine-alcohol in the intention-to-treat population. This study is registered with ClinicalTrials.gov, number NCT01629550 and is closed to new participants.
Between Oct 26, 2012, and Feb 12, 2014, 2546 patients were eligible to participate in the study. We randomly assigned 1181 patients (2547 catheters) to chlorhexidine-alcohol (594 patients with scrubbing, 587 without) and 1168 (2612 catheters) to povidone iodine-alcohol (580 patients with scrubbing, 588 without). Chlorhexidine-alcohol was associated with lower incidence of catheter-related infections (0·28 vs 1·77 per 1000 catheter-days with povidone iodine-alcohol; hazard ratio 0·15, 95% CI 0·05-0·41; p=0·0002). Scrubbing was not associated with a significant difference in catheter colonisation (p=0·3877). No systemic adverse events were reported, but severe skin reactions occurred more frequently in those assigned to chlorhexidine-alcohol (27 [3%] patients vs seven [1%] with povidone iodine-alcohol; p=0·0017) and led to chlorhexidine discontinuation in two patients.
For skin antisepsis, chlorhexidine-alcohol provides greater protection against short-term catheter-related infections than does povidone iodine-alcohol and should be included in all bundles for prevention of intravascular catheter-related infections.
University Hospital of Poitiers, CareFusion.
血管内导管相关感染是医疗保健中常见的危及生命的事件,但通过提高护理质量可以降低感染发生率。优化皮肤消毒对于预防短期导管相关感染至关重要。我们假设氯己定-酒精比聚维酮碘-酒精作为皮肤消毒剂更能有效预防血管内导管相关感染。
在这项采用 2×2 析因设计的开放性标签随机对照试验中,我们纳入了入住法国 11 个重症监护病房的连续成年患者(年龄≥18 岁),并需要至少一根中心静脉、血液透析或动脉导管。在导管插入之前,我们通过安全的基于网络的随机数生成器(按中心分层的 8 个随机区组)以 1:1:1:1 的比例随机分配患者,使所有血管内导管均用 2%洗必泰-70%异丙醇(洗必泰酒精)或 5%聚维酮碘-69%乙醇(聚维酮碘酒精)准备,在应用消毒剂之前,皮肤是否用清洁剂擦洗。医生和护士未对分组情况进行盲法,但微生物学家和结果评估人员进行了盲法。主要结局是意向治疗人群中氯己定酒精与聚维酮碘酒精的导管相关感染发生率。该研究在 ClinicalTrials.gov 注册,编号为 NCT01629550,现已不再招募新的参与者。
在 2012 年 10 月 26 日至 2014 年 2 月 12 日期间,共有 2546 名患者符合参与研究的条件。我们随机分配了 1181 名患者(2547 根导管)接受氯己定酒精(594 名患者进行擦洗,587 名患者未进行擦洗),1168 名患者(2612 根导管)接受聚维酮碘酒精(580 名患者进行擦洗,588 名患者未进行擦洗)。与聚维酮碘酒精相比,氯己定酒精与较低的导管相关感染发生率相关(聚维酮碘酒精为每 1000 导管日 1.77 例,氯己定酒精为 0.28 例;风险比 0.15,95%CI 0.05-0.41;p=0.0002)。擦洗与导管定植无显著差异(p=0.3877)。未报告全身不良事件,但与使用聚维酮碘酒精相比,接受氯己定酒精的患者皮肤反应更频繁(严重皮肤反应分别为 27 [3%]例和 7 [1%]例;p=0.0017),并导致两名患者停止使用氯己定。
对于皮肤消毒,氯己定酒精比聚维酮碘酒精能提供更好的短期导管相关感染保护,应纳入所有预防血管内导管相关感染的预防方案中。
普瓦提埃大学医院、CareFusion。